Elevated plasma p-tau217 signaled cognitive decline and dementia risk in people with Down syndrome. High p-tau217 and GFAP levels predicted future amyloid buildup. Down syndrome-related Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback